Abstract:Qingqiang Dai, Tianqi Zhang, Chen Li Department of Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China Correspondence: Chen Li Department of Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China Tel +86-21-64670644 Fax +86-21-64393909 Email leedoctor@sina.com Background: Many studies showed that long non-coding RNA MALAT1 is served as an oncogene. However, the specific role of MALAT1 in gastric cancer is not fully elucidated. The aim of this study is to elucidate the regulatory effects of MALAT1 on tumor development and cisplatin resistance in gastric cancer. Methods: TCGA database was applied to investigate the expression levels of MALAT1 in GC tissues and normal gastric tissues and its correlation with GC patients' survival. Univariate and multivariate analysis were performed to investigate whether MALAT1 expression is an independent risk for overall survival of gastric cancer patients. The expression of MALAT1 was detected by Quantitative real-time PCR. After knockdown or overexpression of MALAT1, the cellular functions of GC cells were detected by cell-proliferation, flow cytometry, transwell assay and colony formation assays, respectively. Western blot analysis was performed to detect the protein levels of Bcl-2 and key genes in the PI3K/AKT pathway in GC cells. Finally, CCK-8 assay was performed to explore the effect of MALAT1 on cisplatin resistance of GC cells. Results: Higher expression of MALAT1 was detected in GC tissues than that of adjacent normal tissues, high MALAT1 expression is an independent risk for overall survival of gastric cancer patients. Knockdown of MALAT1 inhibited proliferation, migration and invasion of GC cells, while overexpression of MALAT1 Overexpression of MALAT1 yielded opposite results. Western blot results showed that protein expressions of p-PI3K, p-AKT and p-STAT3 were downregulated after MALAT1 knockdown in GC cells, while these proteins were upregulated after MALAT1 overexpression. Additionally, the IC 50 in MGC803/CDDP cells transfected with si-MALAT1 was lower than in those transfected with si-NC. The apoptotic rate in MGC803 cells transfected with pcDNA-MALAT1 was remarkably lower than those transfected with NC. Conclusion: We demonstrated that MALAT1 is highly expressed in GC, high MALAT1 expression is an independent risk factor for OS among GC patients. Moreover, MALAT1 promotes malignant progression of GC and contributes to cisplatin resistance of GC cells, indicating MALAT1 may serve as a biological hallmark for predicting the prognosis of GC. Keywords: gastric cancer, MALAT1, proliferation, migration and invasion, cisplatin resistance

IDDF2021-ABS-0109 Obg-like ATpase 1 (OLA1) contributes to gastric cancer progression and can be a novel therapeutic target

Obg-Like Atpase 1 Regulates Global Protein Serine/Threonine Phosphorylation In Cancer Cells By Suppressing The Gsk3 Beta-Inhibitor 2-Pp1 Positive Feedback Loop

OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis

Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer

LGALS9B stabilizes EEF1D protein and activates the PI3K/AKT signaling pathway to promote gastric cancer occurrence and metastasis

The long non-coding RNA OLC8 enhances gastric cancer by interaction with IL-11

Low Expression Of 2 '-5 ' Oligoadenylate Synthetase 1 Predicted Poor Prognosis In Colorectal Cancer

Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1

ATP11A Promotes Epithelial-mesenchymal Transition in Gastric Cancer Cells via the Hippo Pathway

Identification and validation of Cystatin A as a novel promising therapeutic target for gastric cancer

Overexpression of Gnao1 Correlates with Poor Prognosis in Patients with Gastric Cancer and Plays A Role in Gastric Cancer Cell Proliferation and Apoptosis

Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer

The immunological landscape and silico analysis of key paraptosis regulator LPAR1 in gastric cancer patients

Establishment of Golgi apparatus-related genes signature to predict the prognosis and immunotherapy response in gastric cancer patients

Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway

C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells

Ginkgolic Acid (GA) Inhibits the Growth of OCa by Inhibiting lncRNA MALAT1/JAK2 Axis

TOB1 inhibits the gastric cancer progression by focal adhesion pathway and ERK pathway based on transcriptional and metabolic sequencing

Mining the Role of Angiopoietin‐like Protein Family in Gastric Cancer and Seeking Potential Therapeutic Targets by Integrative Bioinformatics Analysis

APAF1‐Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly